{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Department of Psychiatry & Biobehavioral Sciences, UCLA, Los Angeles, California, USA.",
    "Vanderbilt University School of Medicine, Nashville, Tennessee, USA.",
    "Department of Neurosurgery, UCLA, Los Angeles, California, USA.",
    "UCLA-Caltech Medical Scientist Training Program, Los Angeles, California, USA.",
    "Department of Psychology, Staglin Center for Brain and Behavioral Health, UCLA, Los Angeles, California, USA."
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Alexander Bystritsky"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Andrew A.E.D. Bishay",
      "orcid": "0009-0005-7854-3763"
    },
    {
      "affs": [
        0,
        2,
        3
      ],
      "name": "Norman M. Spivak"
    },
    {
      "affs": [
        0
      ],
      "name": "Rod Paulsen"
    },
    {
      "affs": [
        0,
        4
      ],
      "name": "Michael Treanor"
    },
    {
      "affs": [
        0,
        4
      ],
      "name": "Michael S. Fanselow"
    },
    {
      "affs": [
        0,
        4
      ],
      "name": "Michelle G. Craske"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7qwqr6hnjqtkc.bib",
  "cited_by": 0,
  "doi": "10.1177/28314425261505125",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13735752/",
  "id": "7qwqr6hnjqtkc",
  "issns": [
    "2831-4425",
    "2831-4433"
  ],
  "landing_url": "https://doi.org/10.1177/28314425261505125",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Article"
    ],
    [
      "openalex",
      "3203|Psychedelics and Drug Studies"
    ]
  ],
  "openalex": "W7225262295",
  "pdf_url": null,
  "pmcid": "PMC13735752",
  "pmid": "42990949",
  "published": "2026-11-04",
  "publisher": "SAGE Publications",
  "ris": "https://research.draconitic.com/paper/7qwqr6hnjqtkc.ris",
  "sources": [
    {
      "first_seen": "2026-11-09T12:21:22Z",
      "native_id": "PMC13735752",
      "source": "pmc",
      "url": "https://doi.org/10.1177/28314425261505125"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:3203|Psychedelics and Drug Studies",
      "subfield": "psychiatry"
    }
  ],
  "title": "Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder",
  "title_text": "Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T12:21:22Z",
  "url": "https://research.draconitic.com/paper/7qwqr6hnjqtkc",
  "venue": "Psychedelic Medicine",
  "versions": []
}